BECTON, DICKINSON AND COMPANY Other Nonoperating Expense
BECTON, DICKINSON AND COMPANY (BDX) reported Other Nonoperating Expense of -$1.00 million for the 12-month period ending 2022-09-30, per its 10-K filed 2022-11-22.
Discontinued › Income Statement › Other Income
us-gaap:OtherNonoperatingExpense · last filed 2022-11-22
- BECTON, DICKINSON AND COMPANY other nonoperating expense for fiscal 2022 was -$1.00M, a 116.67% decline from fiscal 2021.
- BECTON, DICKINSON AND COMPANY other nonoperating expense for fiscal 2021 was $6.00M.
- BECTON, DICKINSON AND COMPANY other nonoperating expense for fiscal 2020 was -$5.00M.
- BECTON, DICKINSON AND COMPANY other nonoperating expense for fiscal 2019 was -$4.00M, a 233.33% decline from fiscal 2018.
| Period end | Other Nonoperating Expense 12 month | Other Nonoperating Expense 12 month as first filed |
|---|---|---|
| 2022-09-30 | -$1.00M 10-K · filed 2022-11-22 | |
| 2021-09-30 | $6.00M 10-K · filed 2022-11-22 | $3.00M 10-K · filed 2021-11-24 |
| 2020-09-30 | -$5.00M 10-K · filed 2022-11-22 | $3.00M 10-K · filed 2020-11-25 |
| 2019-09-30 | -$4.00M 10-K · filed 2021-11-24 | $2.00M 10-K · filed 2020-11-25 |
| 2018-09-30 | $3.00M 10-K · filed 2020-11-25 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| DEXCOM INC (DXCM) | United States | $33.004B | 25.42 |
| BOSTON SCIENTIFIC CORP (BSX) | United States | $64.781B | 17.29 |
| WEST PHARMACEUTICAL SERVICES INC (WST) | United States | $26.288B | 43.14 |
| Solventum Corp (SOLV) | United States | $15.085B | 9.16 |
| Penumbra Inc (PEN) | United States | $12.596B | 77.33 |
| BAXTER INTERNATIONAL INC (BAX) | United States | $12.139B | -10.35 |
| 3M CO (MMM) | United States | $86.404B | 27.87 |
| GLOBUS MEDICAL INC (GMED) | United States | $9.977B | 20.03 |
| INSULET CORP (PODD) | United States | $9.420B | 28.12 |
| GLAUKOS Corp (GKOS) | United States | $9.135B | -43.73 |